These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8065144

  • 21. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides.
    Schmidt WE, Choudhury AR, Siegel EG, Löser C, Conlon JM, Fölsch UR, Creutzfeldt W.
    Regul Pept; 1989 Jan; 24(1):67-79. PubMed ID: 2544930
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.
    Digestion; 1989 Jan; 42(2):61-9. PubMed ID: 2475379
    [Abstract] [Full Text] [Related]

  • 24. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat.
    Beckh K, Göke R, Ruff W, Koop I, Arnold R, Adler G.
    Digestion; 1991 Jan; 48(2):98-103. PubMed ID: 1868975
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H, Yomota E, Kume E, Shikano T, Endo T, Nagasaki M.
    Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA.
    Cancer Lett; 1991 Jul 26; 59(1):45-50. PubMed ID: 1878860
    [Abstract] [Full Text] [Related]

  • 30. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G, Kisfalvi K, Pelosini I, D'Amato M, Scarpignato C.
    Br J Pharmacol; 1998 Jun 26; 124(3):435-40. PubMed ID: 9647465
    [Abstract] [Full Text] [Related]

  • 31. Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.
    Ogura M, Kubota Y, Inoue K.
    J Gastroenterol; 1996 Jun 26; 31(3):414-9. PubMed ID: 8726834
    [Abstract] [Full Text] [Related]

  • 32. Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters.
    Douglas BR, Woutersen RA, Jansen JB, Rovati LC, Lamers CB.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):209-14. PubMed ID: 2721553
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H, Yazaki N, Yomota E, Shikano T, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 Sep 26; 312(2):227-33. PubMed ID: 8894600
    [Abstract] [Full Text] [Related]

  • 34. Demonstration of a new resonance peak by proton NMR in rat pancreas stimulated with caerulein.
    Esclassan J, Murat C, Aired S, Vincensini P, Hollande E.
    Pancreas; 1990 Sep 26; 5(5):580-8. PubMed ID: 2235969
    [Abstract] [Full Text] [Related]

  • 35. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K, Saito T, Wakatsuki K, Saeki M, Kato T, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1998 Jan 26; 48(1):52-4. PubMed ID: 9522032
    [Abstract] [Full Text] [Related]

  • 36. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK, Permert J, Kazakoff KR, Pour PM, Zuker KA, Bilchik AJ, Adrian TE.
    Carcinogenesis; 1993 May 26; 14(5):1021-6. PubMed ID: 7684953
    [Abstract] [Full Text] [Related]

  • 37. Modulation of rat pancreatic muscarinic cholinergic receptors by caerulein.
    Delhaye M, Taton G, Poirier G, Larose L, St-James S, Morisset J.
    Biochem Pharmacol; 1985 Apr 01; 34(7):1057-63. PubMed ID: 2580534
    [Abstract] [Full Text] [Related]

  • 38. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
    Varga G, Kordás K, Burghardt B, Gacsályi I, Szénási G.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):315-23. PubMed ID: 10079007
    [Abstract] [Full Text] [Related]

  • 39. Time-specific development of pancreatic hypersecretory capacity during chronic caerulein treatment in rats.
    Varga G, Dobronyi I, Papp M.
    Scand J Gastroenterol; 1989 Jun 19; 24(5):565-70. PubMed ID: 2762755
    [Abstract] [Full Text] [Related]

  • 40. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
    Sakamoto C, Otsuki M, Ohki A, Yuu H, Maeda M, Yamasaki T, Baba S.
    Endocrinology; 1982 Feb 19; 110(2):398-402. PubMed ID: 6173205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.